DEBT - Components of Debt (Details) shares in Thousands				1 Months Ended		3 Months Ended
	Aug. 12, 2022 USD ($)	Aug. 11, 2022 USD ($) license	Aug. 27, 2021 USD ($) covenant quarter shares	Dec. 31, 2022 USD ($)	Aug. 31, 2022 USD ($) license	Mar. 31, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2023 USD ($)
Debt Instrument [Line Items]
Finance leases						$ 1,574,000			$ 1,692,000
Total debt						315,981,000			315,149,000
Current portion of debt, net						21,820,000			11,148,000
Long-term debt						294,161,000			304,001,000
Less: unamortized deferred financing costs						5,463,000			6,436,000
Long-term debt, net						288,698,000			297,565,000
Outstanding claim amount, total							$ 22,794,000
Illinois Licenses
Debt Instrument [Line Items]
Number of licenses acquired | license		1			2
Assets acquired long-term debt		$ 2,500,000
Ohio Patient Access LLC (“OPA”)
Debt Instrument [Line Items]
Assets acquired long-term debt	$ 11,000,000
Asset acquisition, net of discount						3,010,000
2021 Credit Facility
Debt Instrument [Line Items]
Debt						275,000,000			275,000,000
Debt instrument, amount			$ 210,000,000
Maximum borrowing capacity if amended			$ 275,000,000
Maximum borrowing capacity						275,000,000
Interest rate (percent)			9.50%
Extension term			364 days
Number of financial covenants | covenant			2
Covenant, minimum liquidity at fiscal quarter end			$ 20,000,000
Number of consecutive quarters used for covenant measurement | quarter			4
2021 Credit Facility | Debt Instrument, Covenant, Period Two
Debt Instrument [Line Items]
Covenant, maximum EBITDA to cash interest expense ratio			2.50
Sellers' Notes
Debt Instrument [Line Items]
Debt						19,442,000			18,591,000
Current portion of debt, net						1,310,000
Sellers' Notes | Illinois Licenses
Debt Instrument [Line Items]
Current portion of debt, net					$ 8,100,000
Sellers' Notes | Ohio Patient Access LLC (“OPA”)
Debt Instrument [Line Items]
Current portion of debt, net						10,032,000
Long-term debt, net									9,705,000
Finance liabilities
Debt Instrument [Line Items]
Debt						18,100,000			18,100,000
Financing Agreement
Debt Instrument [Line Items]
Debt						$ 1,865,000			$ 1,766,000
Interest rate (percent)						10.00%
Proceeds from issuance of debt				$ 19,364,000
Interests in a retention tax credit claim				$ 22,794,000
Outstanding claim amount, remaining						$ 1,964,000
2022 Loan
Debt Instrument [Line Items]
Additional borrowings								$ 65,000,000
Deferred finance costs gross			$ 8,806,000
Additional debt issuance cost			$ 7,606,000
Class A common stock | 2022 Loan
Debt Instrument [Line Items]
Stock and warrants issued during period shares preferred stock and warrants ( in shares) | shares			3,130
Stock and warrants issued during period, value, preferred stock and warrants			$ 2,639,000